AI Sight Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

AI Sight General Information

Description

Developer of an AI diabetic retinal screening system designed to provide WHO-recommended diabetic eye screening services. The company engages in developing sensitive and specific, low-cost, web-based diagnostic tools capable of image interpretation across diabetic retinopathy (DR) disease severity and treatment intervention points, enabling healthcare sector to identify borderline and contentious cases and pass them on for human assessment locally or remotely, integrated within the system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Innovation Centre Sci-Tech Daresbury
  • Keckwick Lane, Cheshire
  • Daresbury WA4 4FS
  • England, United Kingdom
+44 07951
Primary Industry
Diagnostic Equipment
Corporate Office
  • The Innovation Centre Sci-Tech Daresbury
  • Keckwick Lane, Cheshire
  • Daresbury WA4 4FS
  • England, United Kingdom
+44 07951

AI Sight Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AI Sight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Clinical Trials - General
5. Early Stage VC Cancelled Clinical Trials - General
4. Early Stage VC 17-Sep-2024 Completed Clinical Trials - General
3. Early Stage VC 11-Aug-2023 Completed Clinical Trials - General
2. Accelerator/Incubator Completed Clinical Trials - General
1. University Spin-Out 01-Jan-2022 Completed Clinical Trials - General
To view AI Sight’s complete valuation and funding history, request access »

AI Sight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view AI Sight’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AI Sight Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI diabetic retinal screening system designed to provide WHO-recommended diabetic eye screening services
Diagnostic Equipment
Daresbury, United Kingdom
6 As of 2024

San Francisco, CA
 

Coimbra, Portugal
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AI Sight Competitors (3)

One of AI Sight’s 3 competitors is Eyenuk, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eyenuk Venture Capital-Backed San Francisco, CA
Retmarker Formerly VC-backed Coimbra, Portugal
RetinaLyze System Accelerator/Incubator Backed Hellerup, Denmark
You’re viewing 3 of 3 competitors. Get the full list »

AI Sight Patents

AI Sight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4552077-A1 A computer-implemented method of determining if a fundus image requires referral for investigation for a disease Pending 20-Jul-2022
US-20260038670-A1 A computer-implemented method of determining if a fundus image requires referral for investigation for a disease Pending 20-Jul-2022

AI Sight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AI Sight Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enterprise Investment Fund Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Pitalia Capital Family Office Minority
KCP Nominees Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

AI Sight FAQs

  • When was AI Sight founded?

    AI Sight was founded in 2022.

  • Where is AI Sight headquartered?

    AI Sight is headquartered in Daresbury, United Kingdom.

  • What is the size of AI Sight?

    AI Sight has 6 total employees.

  • What industry is AI Sight in?

    AI Sight’s primary industry is Diagnostic Equipment.

  • Is AI Sight a private or public company?

    AI Sight is a Private company.

  • What is AI Sight’s current revenue?

    The current revenue for AI Sight is .

  • How much funding has AI Sight raised over time?

    AI Sight has raised $1.22M.

  • Who are AI Sight’s investors?

    Enterprise Investment Fund, , , Pitalia Capital, and KCP Nominees are 5 of 7 investors who have invested in AI Sight.

  • Who are AI Sight’s competitors?

    Eyenuk, Retmarker, and RetinaLyze System are competitors of AI Sight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process